Entrada Therapeutics Reports First Quarter 2023 Financial Results

Go back to Entrada Therapeutics Reports First Quarter 2023 Financial Results
(NASDAQ: TRDA) Delayed: 7.45 -0.22 (2.87%)
Previous Close $7.67    52 Week High
Open $7.74    52 Week Low
Day High $7.77    P/E N/A 
Day Low $7.37    EPS
Volume 236,443